scholarly article | Q13442814 |
P50 | author | Eva Cecilie Bonefeld-Jørgensen | Q68132652 |
P2093 | author name string | Lisbeth Stigaard Kjeldsen | |
P2860 | cites work | Gestational exposure to perfluorooctane sulfonate suppresses immune function in B6C3F1 mice | Q23911989 |
Estrogen-like properties of fluorotelomer alcohols as revealed by mcf-7 breast cancer cell proliferation | Q24536247 | ||
Prenatal Exposure to Perfluorinated Chemicals and Behavioral or Coordination Problems at Age 7 Years | Q24609654 | ||
Exposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in U.S. children 12-15 years of age | Q24629288 | ||
Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth | Q24647791 | ||
Prenatal exposure to perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS) and maternally reported developmental milestones in infancy | Q24651358 | ||
Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators | Q24652367 | ||
Do perfluoroalkyl compounds impair human semen quality? | Q24657367 | ||
Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort | Q24680484 | ||
Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth | Q24680500 | ||
Chemistry and structural biology of androgen receptor | Q24685498 | ||
Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action. | Q24810680 | ||
Prediction and assessment of the effects of mixtures of four xenoestrogens | Q24810860 | ||
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators | Q28304744 | ||
Disruption of androgen receptor signaling in males by environmental chemicals | Q28391744 | ||
Effects of perfluorooctane sulfonate on rat thyroid hormone biosynthesis and metabolism | Q28576821 | ||
Estrogen receptors: how do they signal and what are their targets | Q29617958 | ||
Endocrine-disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-octylphenol in vitro: new data and a brief review | Q31141856 | ||
Biodegradation of perfluorinated compounds | Q33386161 | ||
Perfluorochemical surfactants in the environment | Q33958995 | ||
Perfluorinated compounds--exposure assessment for the general population in Western countries | Q34012353 | ||
Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals | Q34207902 | ||
Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors | Q34234016 | ||
Xenoestrogens: mechanisms of action and detection methods | Q34270735 | ||
The developmental toxicity of perfluoroalkyl acids and their derivatives | Q34331477 | ||
The toxicology of perfluorooctanoate | Q34343282 | ||
Partition of environmental chemicals between maternal and fetal blood and tissues | Q34540744 | ||
Estrogen-like activity of perfluoroalkyl acids in vivo and interaction with human and rainbow trout estrogen receptors in vitro. | Q34601427 | ||
Perfluoroalkyl acids: a review of monitoring and toxicological findings | Q34630884 | ||
Of mice and men: the evolving phenotype of aromatase deficiency | Q34651793 | ||
Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers | Q34680365 | ||
Estimating consumer exposure to PFOS and PFOA. | Q34770851 | ||
Maternal levels of perfluorinated chemicals and subfecundity | Q34931926 | ||
Perfluorinated compounds are related to breast cancer risk in Greenlandic Inuit: a case control study | Q35461376 | ||
Serum vaccine antibody concentrations in children exposed to perfluorinated compounds | Q35478107 | ||
PPARalpha agonist-induced rodent tumors: modes of action and human relevance | Q35631058 | ||
Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes | Q36032594 | ||
Effects of environmentally-relevant levels of perfluorooctane sulfonate on clinical parameters and immunological functions in B6C3F1 mice | Q36245081 | ||
Genomic profiling reveals an alternate mechanism for hepatic tumor promotion by perfluorooctanoic acid in rainbow trout | Q36838204 | ||
Androgen receptor structural and functional elements: role and regulation in prostate cancer | Q36884596 | ||
Endocrine disruptors and estrogenic effects on male reproductive axis | Q37035017 | ||
A review of independent action compared to concentration addition as reference models for mixtures of compounds with different molecular target sites. | Q37083614 | ||
Contamination, bioaccumulation and toxic effects of perfluorinated chemicals (PFCs) in the water environment: a review paper | Q37598518 | ||
Immunotoxicity of perfluorinated compounds: recent developments. | Q37959888 | ||
Perfluorinated compounds | Q38040335 | ||
Association of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) with age of puberty among children living near a chemical plant | Q39189165 | ||
Fluorochemicals used in food packaging inhibit male sex hormone synthesis. | Q39246825 | ||
Comparison of in vitro cytotoxicity, estrogenicity and anti-estrogenicity of triclosan, perfluorooctane sulfonate and perfluorooctanoic acid | Q39470464 | ||
Perfluorinated compounds differentially affect steroidogenesis and viability in the human adrenocortical carcinoma (H295R) in vitro cell assay | Q39530533 | ||
Effects of plasticizers and their mixtures on estrogen receptor and thyroid hormone functions | Q39848010 | ||
Plastic components affect the activation of the aryl hydrocarbon and the androgen receptor | Q40009773 | ||
Impact of environmental chemicals on the thyroid hormone function in pituitary rat GH3 cells | Q40362684 | ||
Effect of pesticides on estrogen receptor transactivation in vitro: a comparison of stable transfected MVLN and transient transfected MCF-7 cells | Q40363057 | ||
Synergisms with mixtures of xenoestrogens: a reevaluation using the method of isoboles | Q40995728 | ||
MVLN cells: a bioluminescent MCE-7-derived cell line to study the modulation of estrogenic activity | Q41528638 | ||
A new cellular model of response to estrogens: a bioluminescent test to characterize (anti) estrogen molecules. | Q41718949 | ||
The effects of perfluoro-octanoic acid on hepatic peroxisome proliferation and related parameters show no sex-related differences in mice | Q41783961 | ||
The combined antiandrogenic effects of five commonly used pesticides. | Q42172005 | ||
Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids | Q42540655 | ||
Effect of the peroxisome proliferator, ammonium perfluorooctanoate (C8), on hepatic aromatase activity in adult male Crl:CD BR (CD) rats | Q42553994 | ||
Perfluorooctane sulfonate (PFOS) affects hormone receptor activity, steroidogenesis, and expression of endocrine-related genes in vitro and in vivo | Q42715289 | ||
Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid | Q42801273 | ||
Determining the molecular interactions of perfluorinated carboxylic acids with human sera and isolated human serum albumin using nuclear magnetic resonance spectroscopy. | Q42915431 | ||
Prenatal and postnatal impact of perfluorooctane sulfonate (PFOS) on rat development: a cross-foster study on chemical burden and thyroid hormone system | Q43238768 | ||
Determinants of fetal exposure to polyfluoroalkyl compounds in Baltimore, Maryland | Q43822053 | ||
Effects of currently used pesticides in assays for estrogenicity, androgenicity, and aromatase activity in vitro | Q43909287 | ||
Induction of Leydig cell adenomas by ammonium perfluorooctanoate: a possible endocrine-related mechanism | Q44257091 | ||
Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation | Q44458021 | ||
Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations | Q44458023 | ||
The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. | Q44809487 | ||
Characterisation of human exposure pathways to perfluorinated compounds--comparing exposure estimates with biomarkers of exposure | Q45357022 | ||
Neonatal exposure to PFOS and PFOA in mice results in changes in proteins which are important for neuronal growth and synaptogenesis in the developing brain | Q46124668 | ||
Perfluorinated compounds in human breast milk from several Asian countries, and in infant formula and dairy milk from the United States | Q46206901 | ||
Effects of perfluoroalkyl acids on the function of the thyroid hormone and the aryl hydrocarbon receptor | Q46316312 | ||
Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters | Q46343531 | ||
Induction of hepatic peroxisome proliferation by 8-2 telomer alcohol feeding in mice: formation of perfluorooctanoic acid in the liver | Q46486142 | ||
Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate | Q46687851 | ||
Evaluation of estrogenic activities and mechanism of action of perfluorinated chemicals determined by vitellogenin induction in primary cultured tilapia hepatocytes | Q46915988 | ||
Estrogen-like properties of perfluorooctanoic acid as revealed by expressing hepatic estrogen-responsive genes in rare minnows (Gobiocypris rarus). | Q46946288 | ||
Determination of perfluorooctanoic acid and perfluorooctanesulfonate in human tissues by liquid chromatography/single quadrupole mass spectrometry. | Q48444775 | ||
The faroes statement: human health effects of developmental exposure to chemicals in our environment. | Q51966302 | ||
Perfluoroalkyl acids and related chemistries--toxicokinetics and modes of action. | Q53225736 | ||
Peer Reviewed: Perfluorochemical Surfactants in the Environment | Q54020640 | ||
Estrogenic effects of fluorotelomer alcohols for human estrogen receptor isoforms alpha and beta in vitro. | Q54384245 | ||
Effects of Ammonium Perfluorooctanoate on Leydig-Cell Function: In Vitro, in Vivo, and ex Vivo Studies | Q59663186 | ||
Exposure to perfluorinated compounds and human semen quality in arctic and European populations | Q61860998 | ||
Biochemical effects and zonal heterogeneity of peroxisome proliferation induced by perfluorocarboxylic acids in rat liver | Q69963675 | ||
The induction of peroxisome proliferation in rat liver by perfluorinated fatty acids, metabolically inert derivatives of fatty acids | Q93648772 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 14 | |
P304 | page(s) | 8031-8044 | |
P577 | publication date | 2013-06-14 | |
P1433 | published in | Environmental Science and Pollution Research | Q15750698 |
P1476 | title | Perfluorinated compounds affect the function of sex hormone receptors | |
P478 | volume | 20 |
Q48051836 | Adsorption of perfluorocarboxylic acids at the silica surface |
Q46250845 | Analysis of PFAAs in American alligators part 1: Concentrations in alligators harvested for consumption during South Carolina public hunts. |
Q47389424 | Analysis of PFAAs in American alligators part 2: Potential dietary exposure of South Carolina hunters from recreationally harvested alligator meat |
Q90113647 | Application of the Key Characteristics of Carcinogens to Per and Polyfluoroalkyl Substances |
Q99556536 | Associations between prenatal maternal exposure to per- and polyfluoroalkyl substances (PFAS) and polybrominated diphenyl ethers (PBDEs) and birth outcomes among pregnant women in San Francisco |
Q64260723 | Associations of Fetal Growth Outcomes with Measures of the Combined Xenoestrogenic Activity of Maternal Serum Perfluorinated Alkyl Acids in Danish Pregnant Women |
Q35250864 | Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: a nested case-control study in the Danish National Birth Cohort |
Q60913748 | Autism spectrum disorders, endocrine disrupting compounds, and heavy metals in amniotic fluid: a case-control study |
Q35119347 | Bias from conditioning on live birth in pregnancy cohorts: an illustration based on neurodevelopment in children after prenatal exposure to organic pollutants |
Q34730721 | Biomonitoring and hormone-disrupting effect biomarkers of persistent organic pollutants in vitro and ex vivo |
Q34430357 | Breast cancer risk after exposure to perfluorinated compounds in Danish women: a case-control study nested in the Danish National Birth Cohort |
Q38716034 | Cosmetics as endocrine disruptors: are they a health risk? |
Q38176554 | DNA microarray-based gene expression profiling of estrogenic chemicals |
Q93123912 | Derivation of a chronic reference dose for perfluorohexane sulfonate (PFHxS) for reproductive toxicity in mice |
Q60284100 | Developmental Origins of Disease: Emerging Prenatal Risk Factors and Future Disease Risk |
Q47364834 | Drinking water contamination from perfluoroalkyl substances (PFAS): an ecological mortality study in the Veneto Region, Italy |
Q28079540 | Effects of Environmental Exposures on Fetal and Childhood Growth Trajectories |
Q30874167 | Endocrine, biotransformation, and oxidative stress responses in salmon hepatocytes exposed to chemically induced hypoxia and perfluorooctane sulfonamide (PFOSA), given singly or in combination |
Q43307803 | Endocrine-disrupting effects of compounds in Danish streams |
Q51067944 | Estrogen receptor beta mediates hepatotoxicity induced by perfluorooctane sulfonate in mouse. |
Q61849031 | Exposure to Perfluoroalkyl Substances during Fetal Life and Pubertal Development in Boys and Girls from the Danish National Birth Cohort |
Q38652297 | Exposure to modern, widespread environmental endocrine disrupting chemicals and their effect on the reproductive potential of women: an overview of current epidemiological evidence |
Q52671335 | Fluorinated alkyl substances and technical mixtures used in food paper-packaging exhibit endocrine-related activity in vitro. |
Q37196919 | Gastrointestinal Elimination of Perfluorinated Compounds Using Cholestyramine and Chlorella pyrenoidosa |
Q92058920 | Guanidinocalix[5]arene for sensitive fluorescence detection and magnetic removal of perfluorinated pollutants |
Q37504193 | Health effects associated with measured levels of contaminants in the Arctic |
Q35449176 | Hormonal contraceptive use before and after conception in relation to preterm birth and small for gestational age: an observational cohort study. |
Q49935950 | Impact of perfluorochemicals on human health and reproduction: a male's perspective |
Q36095017 | Longitudinal measures of perfluoroalkyl substances (PFAS) in serum of Gullah African Americans in South Carolina: 2003-2013. |
Q36513368 | Maternal and Neonatal Levels of Perfluoroalkyl Substances in Relation to Gestational Weight Gain |
Q51035022 | Maternal and paternal serum concentrations of perfluoroalkyl and polyfluoroalkyl substances and the secondary sex ratio. |
Q35076573 | Maternal exposure to perfluorinated chemicals and reduced fecundity: the MIREC study |
Q64125808 | Maternal serum concentrations of perfluoroalkyl substances and birth size in British boys |
Q37647684 | Maternal serum levels of perfluoroalkyl substances and organochlorines and indices of fetal growth: a Scandinavian case-cohort study |
Q91961959 | Maternal serum levels of perfluoroalkyl substances in early pregnancy and offspring birth weight |
Q90478818 | Method Development for Effect-Directed Analysis of Endocrine Disrupting Compounds in Human Amniotic Fluid |
Q44987459 | Nordic research on per- and polyfluoroalkyl substances (PFASs). |
Q37501237 | Occurrence investigation of perfluorinated compounds in surface water from East Lake (Wuhan, China) upon rapid and selective magnetic solid-phase extraction |
Q46276468 | PFOS induces proliferation, cell-cycle progression, and malignant phenotype in human breast epithelial cells |
Q38755871 | PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling |
Q92746416 | Per- and Polyfluoroalkyl Substance Plasma Concentrations and Bone Mineral Density in Midchildhood: A Cross-Sectional Study (Project Viva, United States) |
Q100444139 | Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research |
Q61819122 | Per- and polyfluoroalkyl substances (PFAS) in plasma of the West Indian manatee (Trichechus manatus) |
Q38847297 | Perfluorinated chemicals, PFOS and PFOA, enhance the estrogenic effects of 17β-estradiol in T47D human breast cancer cells |
Q90294000 | Perfluorinated compounds binding to estrogen receptor of different species: a molecular dynamic modeling |
Q36968190 | Perfluoroalkyl Acids in Maternal Serum and Indices of Fetal Growth: The Aarhus Birth Cohort |
Q30314285 | Perfluoroalkyl acids in aqueous samples from Germany and Kenya |
Q38265262 | Perfluoroalkyl and polyfluoroalkyl substances and human fetal growth: a systematic review |
Q38856995 | Perfluoroalkyl and polyfluoroalkyl substances and measures of human fertility: a systematic review |
Q30666605 | Perfluoroalkyl and polyfluoroalkyl substances in consumer products. |
Q35562877 | Perfluoroalkyl substances and ovarian hormone concentrations in naturally cycling women |
Q99592078 | Perfluoroalkyl substances are associated with elevated blood pressure and hypertension in highly exposed young adults |
Q41612522 | Perfluorodecanoic acid (PFDA) promotes gastric cell proliferation via sPLA2-IIA |
Q52689096 | Perfluorooctanoic acid (PFOA) exposure promotes proliferation, migration and invasion potential in human breast epithelial cells. |
Q30234122 | Persistent organic contaminants in food : Exposure, hazard potential, and health assessment |
Q34689412 | Phlebotomy treatment for elimination of perfluoroalkyl acids in a highly exposed family: a retrospective case-series |
Q38186063 | Polyfluorinated alkyl phosphate ester surfactants - current knowledge and knowledge gaps |
Q34524819 | Polymorphisms in phase I and phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case-control study in Inuit women |
Q98185257 | Prenatal Exposure to Perfluoroalkyl Substances Associated with Increased Susceptibility to Liver Injury in Children |
Q37674876 | Prenatal Exposure to Perfluoroalkyl Substances and Adiposity in Early and Mid-Childhood |
Q57167619 | Prenatal Exposure to Perfluoroalkyl Substances and Birth Outcomes; An Updated Analysis from the Danish National Birth Cohort |
Q89089334 | Prenatal Exposure to Perfluoroalkyl Substances and IQ Scores at Age 5; a Study in the Danish National Birth Cohort |
Q44964762 | Prenatal exposure to perfluoroalkyl substances and the risk of congenital cerebral palsy in children |
Q36582254 | Programming of metabolic effects in C57BL/6JxFVB mice by in utero and lactational exposure to perfluorooctanoic acid |
Q60185258 | Reproductive Function in a Population of Young Faroese Men with Elevated Exposure to Polychlorinated Biphenyls (PCBs) and Perfluorinated Alkylate Substances (PFAS) |
Q33796226 | Serum levels of environmental pollutants is a risk factor for breast cancer in Inuit: a case control study |
Q37286520 | Testosterone-Mediated Endocrine Function and TH1/TH2 Cytokine Balance after Prenatal Exposure to Perfluorooctane Sulfonate: By Sex Status. |
Q37580534 | The Association of Prenatal Exposure to Perfluorinated Chemicals with Glucocorticoid and Androgenic Hormones in Cord Blood Samples: The Hokkaido Study |
Q56700244 | The Current Epidemiologic Evidence on Exposures to Poly- and Perfluoroalkyl Substances (PFASs) and Male Reproductive Health |
Q44980589 | The Hokkaido Birth Cohort Study on Environment and Children's Health: cohort profile-updated 2017. |
Q92109687 | Toxicokinetics of perfluorobutane sulfonate (PFBS), perfluorohexane-1-sulphonic acid (PFHxS), and perfluorooctane sulfonic acid (PFOS) in male and female Hsd:Sprague Dawley SD rats after intravenous and gavage administration |